HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.

AbstractINTRODUCTION:
Magnetic resonance imaging (MRI) and MR spectroscopy can probe a variety of physiological (e.g. blood vessel permeability) and metabolic characteristics of prostate cancer. However, little is known about the changes in gene expression that underlie the spectral and imaging features observed in prostate cancer. Tumor induced changes in vascular permeability and angiogenesis are thought to contribute to patterns of dynamic contrast enhanced (DCE) MRI images of prostate cancer even though the genetic basis of tumor vasculogenesis is complex and the specific mechanisms underlying these DCEMRI features have not yet been determined.
MATERIALS AND METHODS:
In order to identify the changes in gene expression that correspond to MRS and DCEMRI patterns in human prostate cancers, we have utilized tissue print micropeel techniques to generate "whole mount" molecular maps of radical prostatectomy specimens that correspond to pre-surgical MRI/MRS studies. These molecular maps include RNA expression profiles from both Affymetrix GeneChip microarrays and quantitative reverse transcriptase PCR (qrt-PCR) analysis, as well as immunohistochemical studies.
RESULTS:
Using these methods on patients with prostate cancer, we found robust over-expression of choline kinase a in the majority of primary tumors. We also observed overexpression of neuropeptide Y (NPY), a newly identified angiogenic factor, in a subset of prostate cancers, visualized on DCEMRI.
CONCLUSION:
These studies set the stage for establishing MRI/MRS parameters as validated biomarkers for human prostate cancer.
AuthorsRobert E Lenkinski, B Nicolas Bloch, Fangbing Liu, John V Frangioni, Sven Perner, Mark A Rubin, Elizabeth M Genega, Neil M Rofsky, Sandra M Gaston
JournalMagma (New York, N.Y.) (MAGMA) Vol. 21 Issue 6 Pg. 411-21 (Nov 2008) ISSN: 0968-5243 [Print] Germany
PMID18752015 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, CD34
  • Neuropeptide Y
  • RNA, Messenger
  • RNA, Neoplasm
  • Vascular Endothelial Growth Factor A
  • Choline Kinase
Topics
  • Antigens, CD (genetics)
  • Antigens, CD34 (genetics)
  • Choline Kinase (genetics)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Magnetic Resonance Spectroscopy (methods)
  • Male
  • Neuropeptide Y (genetics)
  • Prostatic Neoplasms (diagnosis, genetics, pathology)
  • RNA, Messenger (genetics)
  • RNA, Neoplasm (genetics)
  • Rectum
  • Vascular Endothelial Growth Factor A (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: